SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GLAXO (GLX)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (203)1/6/1999 10:11:00 AM
From: Zoltan!  Read Replies (1) of 222
 
Dow Jones Newswires -- January 6, 1999

BT Alex. Brown Favors Defensive Stocks For Europe In 1999

LONDON (Dow Jones)--BT Alex. Brown is taking a cautious approach to Europe in 1999, favoring defensive stocks in its Pan-European 15 portfolio.

BTAB said the portfolio "largely favors defensive plays - financially and economically defensive companies - and those expected to benefit from restructuring."

The fifteen stocks are: BG PLC (BRG), British Telecommunications PLC (BTY), Glaxo Wellcome PLC (GLX), Canal Plus SA (F.CLP), Endesa SA (ELE), Mannesmann AG (G.MMN), Nokia Corp. (NOKA), Novartis AG (Z.NOV), Pearson PLC (U.PSO), Powergen PLC (PWG), Rhone-Poulenc SA (RP), Richemont Securities AG (O.RCH), UBS AG (Z.UBS), Telecom Italia SpA (TI) and VNU NV (N.VNU).

Nokia, UBS and Novartis were part of BTAB's Pan-European 15 portfolio last year.
interactive.wsj.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext